These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20023898)

  • 1. Dual anti-angiogenic and cytotoxic properties of ruthenium(III) complexes containing pyrazolato and/or pyrazole ligands.
    Sun RW; Ng MF; Wong EL; Zhang J; Chui SS; Shek L; Lau TC; Che CM
    Dalton Trans; 2009 Dec; (48):10712-6. PubMed ID: 20023898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel ruthenium(III) complex with a tridentate dianionic P,O,O-ligand showing high cytotoxic activity.
    van Rijn JA; Marqués-Gallego P; Reedijk J; Lutz M; Spek AL; Bouwman E
    Dalton Trans; 2009 Dec; (48):10727-30. PubMed ID: 20023901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, molecular structure and evaluation of new organometallic ruthenium anticancer agents.
    Camm KD; El-Sokkary A; Gott AL; Stockley PG; Belyaeva T; McGowan PC
    Dalton Trans; 2009 Dec; (48):10914-25. PubMed ID: 20023922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, single-crystal and solution structure analysis and in vitro cytotoxic activity of two novel complexes of ruthenium(II) with in situ formed flavanone-based ligands.
    Ochocki J; Kasprzak M; Chęcińska L; Erxleben A; Zyner E; Szmigiero L; Garza-Ortiz A; Reedijk J
    Dalton Trans; 2010 Oct; 39(40):9711-8. PubMed ID: 20830400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a strongly apoptotic ruthenium complex through combinatorial coordination chemistry.
    Mulcahy SP; Gründler K; Frias C; Wagner L; Prokop A; Meggers E
    Dalton Trans; 2010 Sep; 39(35):8177-82. PubMed ID: 20689887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A straightforward and generalizable synthetic methodology for the synthesis of ruthenium(II) complexes with thioether ligands from either Ru(III) or Ru(0) precursors.
    Maiti BK; Görls H; Klobes O; Imhof W
    Dalton Trans; 2010 Jun; 39(24):5713-20. PubMed ID: 20495720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, characterization and antitumor properties of two highly cytotoxic ruthenium(iii) complexes with bulky triazolopyrimidine ligands.
    Łakomska I; Fandzloch M; Muzioł T; Lis T; Jezierska J
    Dalton Trans; 2013 May; 42(17):6219-26. PubMed ID: 23328694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, structure, spectra and reactivity of iron(III) complexes of imidazole and pyrazole containing ligands as functional models for catechol dioxygenases.
    Dhanalakshmi T; Suresh E; Palaniandavar M
    Dalton Trans; 2009 Oct; (39):8317-28. PubMed ID: 19789784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity.
    Dougan SJ; Melchart M; Habtemariam A; Parsons S; Sadler PJ
    Inorg Chem; 2006 Dec; 45(26):10882-94. PubMed ID: 17173447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic Ruthenium(II) Complexes of Pyrazolylbenzimidazole Ligands That Inhibit VEGFR2 Phosphorylation.
    Chakraborty A; Roy S; Chakraborty MP; Roy SS; Purkait K; Koley TS; Das R; Acharya M; Mukherjee A
    Inorg Chem; 2021 Dec; 60(23):18379-18394. PubMed ID: 34780170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, characterization and cytotoxic activity of gallium(III) complexes anchored by tridentate pyrazole-based ligands.
    Silva F; Marques F; Santos IC; Paulo A; Rodrigues AS; Rueff J; Santos I
    J Inorg Biochem; 2010 May; 104(5):523-32. PubMed ID: 20149462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bis(acetylacetonato)bis(pyrazolato)ruthenate(iii) as a redox-active scorpionate ligand.
    Yoshida J; Sugawara K; Yuge H; Okabayashi J
    Dalton Trans; 2014 Nov; 43(42):16066-73. PubMed ID: 25238163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ruthenium(II) [3 + 2 + 1] mixed ligand complexes: substituent effect on photolability, photooxidation of bases, photocytotoxicity and photonuclease activity.
    Sathyaraj G; Kiruthika M; Weyhermüller T; Nair BU
    Dalton Trans; 2012 Jul; 41(27):8460-71. PubMed ID: 22652837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of ruthenium(II) complexes with anticancer drugs as ligands. Design of metal-based phototherapeutic agents.
    Cini R; Tamasi G; Defazio S; Corsini M; Zanello P; Messori L; Marcon G; Piccioli F; Orioli P
    Inorg Chem; 2003 Dec; 42(24):8038-52. PubMed ID: 14632524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiproliferative activity of dmoPTA-Ru(II) complexes against human solid tumor cells.
    Ríos-Luci C; León LG; Mena-Cruz A; Pérez-Roth E; Lorenzo-Luis P; Romerosa A; Padrón JM
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4568-71. PubMed ID: 21719285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promising anticancer mono- and dinuclear ruthenium(III) dithiocarbamato complexes: systematic solution studies.
    Nagy EM; Nardon C; Giovagnini L; Marchiò L; Trevisan A; Fregona D
    Dalton Trans; 2011 Nov; 40(44):11885-95. PubMed ID: 21971872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA interaction and cytotoxicity studies of new ruthenium(II) cyclopentadienyl derivative complexes containing heteroaromatic ligands.
    Moreno V; Font-Bardia M; Calvet T; Lorenzo J; Avilés FX; Garcia MH; Morais TS; Valente A; Robalo MP
    J Inorg Biochem; 2011 Feb; 105(2):241-9. PubMed ID: 21194624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, characterization, and anticancer activity of ruthenium-pyrazole complexes.
    David S; Perkins RS; Fronczek FR; Kasiri S; Mandal SS; Srivastava RS
    J Inorg Biochem; 2012 Jun; 111():33-9. PubMed ID: 22484498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, X-ray structure and cytotoxic effect of nickel(II) complexes with pyrazole ligands.
    Sobiesiak M; Lorenz IP; Mayer P; Woźniczka M; Kufelnicki A; Krajewska U; Rozalski M; Budzisz E
    Eur J Med Chem; 2011 Dec; 46(12):5917-26. PubMed ID: 22047642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ruthenium(II) arene anticancer complexes with redox-active diamine ligands.
    Bugarcic T; Habtemariam A; Deeth RJ; Fabbiani FP; Parsons S; Sadler PJ
    Inorg Chem; 2009 Oct; 48(19):9444-53. PubMed ID: 19780621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.